为您找到相关结果约94个

你是不是要搜索 期刊Emapalumab 点击跳转

Emapalumab: First Global Approval

Emapalumab for the treatment of hemophagocytic lymphohistiocytosis

Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

Emapalumab in Primary Hemophagocytic Lymphohistiocytosis

Emapalumab in Primary Hemophagocytic Lymphohistiocytosis REPLY

Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL)

Efficacy and safety of emapalumab in macrophage activation syndrome

Emapalumab for adult and pediatric patients with hemophagocytic lymphohistiocytosis

Emapalumab for Treatment of Impending Graft Failure

Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis

PEDIATRIC REFRACTORY SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS TREATED WITH EMAPALUMAB

PEDIATRIC REFRACTORY SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS SUCCESSFULLY TREATED WITH EMAPALUMAB

EMAPALUMAB IN PEDIATRIC PATIENTS WITH PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: SAFETY & EFFICACY

EMAPALUMAB EXPOSURE-SAFETY RELATIONSHIP IN PATIENTS WITH PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

PREDICTIVE PHARMACOKINETIC MODEL OF EMAPALUMAB PLASMA CONCENTRATIONS IN HEALTHY VOLUNTEERS

为您找到相关结果约94个

共94条页码: 1/7页15条/页